☆ 4.5 Letter

Myeloid malignancies in cancer patients treated with poly(ADP-ribose) polymerase (PARP) inhibitors: a case series

BLOOD CANCER JOURNAL (2022)

Journal

BLOOD CANCER JOURNAL

Volume 12, Issue 1, Pages -

Publisher

SPRINGERNATURE

DOI: 10.1038/s41408-022-00607-7

Keywords

-

Categories

Oncology Hematology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

No Data Available

No Data Available

No Data Available

© Peeref 2019-2024. All rights reserved.